Preliminary Program subject to change
P450 Metabolism Enzymes
Presentation Type	Oral
Summary Statement
Presiders:	Donglu Zhang, Bristol-Myers Squibb, Princeton, NJ Leslie Romanyshyn, Merck & Co., Rahway, NJ
Introductory Remarks P450 in drug discovery and development - Now and the future Ronald E. White, Schering-Plough Research Institute, Kenilworth, NJ The Incorporation of Active and Reactive Metabolite Data into the Drug Discovery Process Griffith Humphreys, Bristol Myers Squibb Pharmaceutical Research Institute, Princeton, NJ Break Human Extrahepatic Cytochrome P450 (CYP) Enzymes: Role in Xenobiotic Metabolism and Toxicity Jun-Yan Hong, UMDNJ, Piscataway, NJ Drug-Drug Interactions: P450 Inhibition and Induction Michael W. Sinz, Bristol_Myers Squibb, Wallingford, CT

General Submissions